Preview Mode Links will not work in preview mode

Apr 1, 2021

Featuring perspectives from Drs Sumanta K Pal and David I Quinn on the following topics:

  • Renal Cell Carcinoma
    • Introduction (0:00)
    • First-line treatment of metastatic RCC (4:49)
    • Relapsed disease (21:26)
  • Urothelial Bladder Cancer (UBC)
    • Immune checkpoint inhibitors (ICIs) for non-muscle-invasive UBC (24:59)
    • (Neo)adjuvant ICIs (28:26)
    • ICIs with or without other systemic therapies; novel strategies (35:13)
    • New data sets further defining the role of enfortumab vedotin in UBC (38:45)
    • Optimal integration of erdafitinib into the management of relapsed/refractory UBC (53:09)

CME information and select publications